Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials - Wikidata - awgldk - TriplyDB

Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials

Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials

http://www.wikidata.org/entity/Q36810470

about

Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome Management of Membranous Nephropathy in Western Countries Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy Cancer risk after cyclophosphamide treatment in idiopathic membranous nephropathy.The calcineurin inhibitor tacrolimus reduces proteinuria in membranous nephropathy accompanied by a decrease in angiopoietin-like-4.Rituximab for the treatment of refractory simultaneous anti-glomerular basement membrane (anti-GBM) and membranous nephropathy Clinical and Immunologic Characteristics of Patients With ANCA-Associated Glomerulonephritis Combined With Membranous Nephropathy: A Retrospective Cohort Study in a Single Chinese Center Complete and Partial Remission as Surrogate End Points in Membranous Nephropathy.Factors affecting the long-term outcomes of idiopathic membranous nephropathy.A retrospective Aliskiren and Losartan study in non-diabetic chronic kidney disease Treatment with rituximab in idiopathic membranous nephropathy.Overview of current and alternative therapies for idiopathic membranous nephropathy.Effect of mycophenolic acid in experimental, nontransplant glomerular diseases: new mechanisms beyond immune cells.Comparison of second-line immunosuppressants for childhood refractory nephrotic syndrome: a systematic review and network meta-analysis.Efficacy and Safety of Tacrolimus Versus Cyclophosphamide for Primary Membranous Nephropathy: A Meta-Analysis.Recent Treatment Advances and New Trials in Adult Nephrotic Syndrome.Treatment of membranous nephropathy: time for a paradigm shift.Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up.Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.Low-dose synthetic adrenocorticotropic hormone-analog therapy for nephrotic patients: results from a single-center pilot study.Balancing cancer risk and efficacy of using cyclophosphamide to treat idiopathic membranous nephropathy.Mouse models of membranous nephropathy: the road less travelled by.Pharmacotherapy options for membranous nephropathy

P2860

Q24193098-22A745CE-0959-448E-B0FF-B7D409FEC7DD Q26740477-9931F88E-AAC4-4347-AAD5-34BB54EA5AA2 Q26747416-4A445B0C-C6F7-4BF8-851D-1D19B752B772 Q33715801-279E4392-40AC-4037-B974-551429F1E010 Q34105415-E4054952-A888-4C88-9022-37170097F0A3 Q35310890-BD0BEB32-D366-4E19-8087-3553B8BC5D2D Q36256090-13746345-9283-4B45-A69B-8B09E88861C7 Q36314982-A1F08976-32CC-4E29-9EDA-D4E197E6767E Q36324367-06DCC116-B35D-4520-8460-9CA8EF811673 Q37322017-DBD74D02-8592-4C91-AE94-0793E66846BC Q37511019-1C4FAAC6-8FAA-41E9-AC5C-EAAE960B28F7 Q38425865-8C2266B5-E001-41EE-B98D-65F019B73044 Q38867651-69940A00-48B1-4ED8-8C32-82583DD3D363 Q38917805-A7C6704B-909F-442C-8D6C-431A08C137D9 Q39022568-587D5F8C-C7D8-4E4F-84D5-3E089DE32DB5 Q39335899-932BAF1D-90AE-4DD0-937E-B9A5D95241BB Q39410091-3081CE85-911F-4859-BA1B-9F174529E0EE Q39648546-FE470765-8236-4724-82E9-EE00C7251675 Q41229115-49A95913-3CA5-454B-81FE-A5E0A3D7FC4E Q41467613-ACA1BCC2-71B2-408C-B253-CD53F650B678 Q42639047-498AE6AE-1C62-425A-A933-B7CED26EC505 Q43087986-2F957D96-5F12-4E89-B079-9CFC072C41F7 Q57701454-BDA7364C-A7EA-46A5-9A07-7A62AD469CFD

P2860

Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials

http://www.wikidata.org/entity/Q36810470

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Immunosuppression for membrano ...... analysis of 36 clinical trials

@ast

Immunosuppression for membrano ...... analysis of 36 clinical trials

@en

type

label

Immunosuppression for membrano ...... analysis of 36 clinical trials

@ast

Immunosuppression for membrano ...... analysis of 36 clinical trials

@en

prefLabel

Immunosuppression for membrano ...... analysis of 36 clinical trials

@ast

Immunosuppression for membrano ...... analysis of 36 clinical trials

@en

P1433

Q36810470-661110A0-4217-49D4-A370-4EB942C90E77

P1476

Q36810470-99A6A13A-BE78-4432-BAE8-9C8C5A7C2CB6

P2093

Q36810470-4C3D07A6-BCC9-4E8D-ADEC-243B94915EA1

Q36810470-577F3720-755D-42F0-936E-57455193424E

Q36810470-6A61019A-B8BA-4C65-B4E5-0F9B7377B54B

Q36810470-A41C696D-96C3-45D6-A5D9-A332B0642169

Q36810470-A4913036-04CC-4FCA-BAD5-93EEEC913E93

Q36810470-B56EDC36-418C-412A-B425-7167888302AF

Q36810470-E0D13F3A-C8FC-4607-93A8-876B5A4E98A7

P2860

Q36810470-04D33638-A085-47AA-9FE1-17A2252CEC7C

Q36810470-22ADA82A-8985-482A-ACA7-18896784CD53

Q36810470-361A5491-9BFF-49CF-B93F-5AE8CC9D3B8E

Q36810470-36ED1D90-BA44-4091-882F-C173ED45103A

Q36810470-38D2BDBC-8321-4094-B9C0-476DC157ABB1

Q36810470-44E0BBCA-2935-4735-82E6-FEB1061E4CBA

Q36810470-5029F12D-F87A-44A0-B368-06F30E352D4F

Q36810470-67F2A50A-6BC0-4438-9DAC-6DAB14D2E72C

Q36810470-72260870-0BD9-4BC1-A559-05E712B030A1

Q36810470-7E645485-BBDA-48A5-A686-F540A71FA0B0

P304

Q36810470-D257F99A-1180-4039-A0FF-CC144D6F5A52

P31

Q36810470-7d079cee-3152-43f7-bc3d-8e943fcfa35e

Q36810470-ED7E40CE-265C-4BD6-AA03-6E62A3666A76

P356

Q36810470-9DA783ED-3F73-468E-B231-E68045C46C50

P433

Q36810470-D047E219-CACF-40C0-9870-56290EC9DA5E

P478

Q36810470-467AE3ED-3C25-43F2-B328-2B24FF0C586A

P50

Q36810470-3197A2CB-5FDA-435C-9FD8-F9FD5E2B9255

P577

Q36810470-2F79921B-FDFF-4C3F-89DC-E872526C1091

P5875

Q36810470-278BEE0C-BE9C-47DB-8CB5-79AC01D4A1EA

P698

Q36810470-E0FECDCC-E142-43C6-895B-A5981BC4F788

P921

Q36810470-57D92AC3-B323-47DB-839E-AC90789444DD

P932

Q36810470-694A5ECC-2ECE-4A58-A85B-836D37F3E78B

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Immunosuppression for membrano ...... analysis of 36 clinical trials

@en

P2093

Arrigo Schieppati

http://www.w3.org/2001/XMLSchema#string

Giovanni A Giuliano

http://www.w3.org/2001/XMLSchema#string

Guangyan Cai

http://www.w3.org/2001/XMLSchema#string

Javier Zamora

http://www.w3.org/2001/XMLSchema#string

Norbert Braun

http://www.w3.org/2001/XMLSchema#string

Xiangmei Chen

http://www.w3.org/2001/XMLSchema#string

Yizhi Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome

Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy

A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints

Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.

A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.

Controversies in the treatment of idiopathic membranous nephropathy.

Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial.

Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.

Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review.

Rituximab in idiopathic membranous nephropathy.

P304

787-796

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.07570712

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235756593

http://www.w3.org/2001/XMLSchema#string

P698

23449768

http://www.w3.org/2001/XMLSchema#string

P921

immunosuppression

P932

3641615

http://www.w3.org/2001/XMLSchema#string